Sort
23,748 grants matching “melanoma”
Development & Characterization of Tyrosinase Epitope Specific TCR Transgenic Mice
$199,125Shikhar Mehrotra · Medical University Of South Carolina · R21 · FY2009 · AR
HUMAN
$199,052Ellen L Jones · Duke University · P01 · FY2008 · CA
TAS::75 0849::TAS ANTI-STATHMIN BIFUNCTIONAL SMALL HAIRPIN RNA: PRECLINICAL DEVE
$199,045Alex Tong · Gradalis, Inc. · N43 · FY2010 · CA
Evaluating the anti-tumor effects of novel curcumin analogs in melanoma
$199,013Gregory B. Lesinski · Ohio State University · R21 · FY2010 · CA
Improved Tumor Targeting of Salmonella VNP20009 via Ice-llama Antibody Guidance
$199,013Andrew Hayhurst · Texas Biomedical Research Institute · R21 · FY2013 · CA
Carotenoids as protectors against UVB induced cutaneous damage.
$199,013Tatiana M Oberyszyn · Ohio State University · R21 · FY2012 · CA
CELL-SPECIFIC ISOTOPE LABELING TO TRACK INTERCELLULAR METABOLITE EXCHANGE IN CANCER
$199,013Gary J Patti · Washington University · R21 · FY2015 · CA
Molecular Risk Assessment in Hereditary Melanoma
$198,988Hensin Tsao · Massachusetts General Hospital · K24 · FY2010 · CA
Transcriptional regulation of NC precursor formation
$198,982Carole B Labonne · Northwestern University · R01 · FY2007 · CA
Selective Cancer Treatment Based on High Frequency Ultrasonic Beam
$198,937Eun Sok Kim · University Of Southern California · R21 · FY2017 · EB
Defining the role of SWI/SNF chromatin remodeling complex mutations during melanoma progression
$198,936Alan Hunter Shain · University Of California, San Francisco · K22 · FY2019 · CA
Defining the role of SWI/SNF chromatin remodeling complex mutations during melanoma progression
$198,936Alan Hunter Shain · University Of California, San Francisco · K22 · FY2018 · CA
Defining the role of SWI/SNF chromatin remodeling complex mutations during melanoma progression
$198,936Alan Hunter Shain · University Of California, San Francisco · K22 · FY2020 · CA
SBIR Topic 255: Clinical Translation of Anti-PECAM-1 Monoclonal Antibody as an
$198,751Robert Debs · Genomic Systems, Llc · N43 · FY2010 · CA
The molecular analysis of Gab3 in NK cell function
$198,750Andrew B Herr · Cincinnati Childrens Hosp Med Ctr · R21 · FY2019 · AI
Treating Melanoma with a Molecularly Engineered, Long Circulating Immunotoxin
$198,750Ashutosh Chilkoti · Duke University · R21 · FY2016 · EB
Regulation of T cell exhaustion by microRNA-720
$198,750You-Wen He · Duke University · R21 · FY2016 · AI
Reducing dietary copper for the treatment of BRaf mutation-positive melanoma
$198,738Christopher M Counter · Duke University · R21 · FY2014 · CA
DNA Repair, Skin Cancer and Overall Cancer Risk
$198,711Anthony J Alberg · Medical University Of South Carolina · R01 · FY2009 · CA
Project 1
$198,657Kunle O Odunsi · Roswell Park Cancer Institute Corp · P50 · FY2025 · CA
Core D: Medicinal Chemistry Core
$198,650Meenhard Herlyn · Wistar Institute · P01 · FY2014 · CA
A NOVEL DRUGGABLE GENETIC VULNERABILITY PATHWAY IN MELANOMA
$198,647Narendra Wajapeyee · University Of Alabama At Birmingham · R01 · FY2019 · CA
Innate Immune Sensing of Rift Valley Fever Virus
$198,538Amy G Hise · Case Western Reserve University · R21 · FY2010 · AI
Project 2 - Joshua Hood, PhD
$198,466Joshua L. Hood · University Of Louisville · P20 · FY2025 · GM
Molecular Regulation of Human Melanoma Metastasis
$198,450University Of Nebraska Medical Center · R01 · FY2005 · CA